Oligonucleotide & Precision Therapeutics (OPT) Congress

Investors

Oligonucleotide & Precision Therapeutics (OPT) Congress

Mar 26, 2019 4:35 PM EDT

James Hamilton, M.D., Arrowhead’s vice president of clinical development, will deliver an oral presentation titled, “siRNA Clinical Development Based on the TRiMTM Platform”

Location

Cambridge, MA

Supporting Materials